Company PharmaCielo Ltd.

Company PharmaCielo Ltd.

PCLO

CA71716K1012

Pharmaceuticals

Equities

PCLO

CA71716K1012

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Alternative Medicine

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Alternative Medicine

Market Closed - Toronto S.E. Other stock markets 03:13:26 2024-04-25 pm EDT			5-day change	1st Jan Change
0.155 ^CAD	-3.12%		-11.43%	-13.89%

Apr. 10	PharmaCielo Ltd. announced that it expects to receive CAD 2 million in funding	CI
Jan. 04	Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products	CI

PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Companyâs all-natural cannabis into standardized, medicinal-grade oil extracts and related products. In Colombia, PharmaCielo Colombia is a licensed cultivator, producer, and distributor of both TetraHydroCannabinol (THC) and Cannabidiol (CBD) medical cannabis for use in Colombia, international export, and research purposes. Ubiquo is a knowledge management and medical consultation system that focuses on creating access to healthcare for Colombians. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate. Ubiquo is used as a communication tool.

CAD in Million	2021	Weight	2022	Weight	Delta
Cannabis 100.0 %	2	100.0 %	5	100.0 %	+172.93%

CAD in Million	2021	Weight	2022	Weight	Delta
Americas 93.4 %	-	-	5	93.4 %	-
Europe 6.6 %	-	-	0	6.6 %	-

Managers	Title	Age	Since
Marc Lustig CEO	Chief Executive Officer	51	20-11-19
Ian Atacan DFI	Director of Finance/CFO	-	21-06-06
Decio Rabelo de Castro Filho CTO	Chief Tech/Sci/R&D Officer	-	22-07-24
Bill Petron BRD	Director/Board Member	-	21-06-09
David Gordon PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Douglas Bache BRD	Director/Board Member	-	19-01-14
Marc Lustig CEO	Chief Executive Officer	51	20-11-19
William Christopher Nicholas BRD	Director/Board Member	-	21-08-31
Ian Atacan DFI	Director of Finance/CFO	-	21-06-06
David Gordon PRN	Corporate Officer/Principal	-	-
Bill Petron BRD	Director/Board Member	-	21-06-09

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	169,745,157	155,388,736 ( 91.54 %)	0	91.54 %

Name	Equities	%	Valuation
Marc Lustig 3.349 %	5,341,238	3.349 %	908 010 $
Bill Petron 2.521 %	4,019,760	2.521 %	683 359 $
Ian Atacan 0.3421 %	545,646	0.3421 %	92 760 $
Diaz Andres Felipe Botero 0.2223 %	354,555	0.2223 %	60 274 $
AdvisorShares Investments LLC 0.2123 %	338,496	0.2123 %	57 544 $
Douglas Bache 0.0439 %	70,000	0.0439 %	11 900 $
William Christopher Nicholas 0.000000 %	0	0.000000 %	- $

PharmaCielo Ltd.

82 Richmond Street East

M5C 1P1, Toronto

http://www.pharmacielo.com

	1st Jan change	Capi.
PHARMACIELO LTD.	-13.89%	19.79M
DONG-E-E-JIAO CO.,LTD.	+37.37%	6.05B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.69%	4.45B
TASLY PHARMACEUTICAL GROUP CO., LTD	-12.46%	3.06B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.12%	3.04B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+0.47%	2.58B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+36.06%	1.79B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.84%	1.66B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-10.60%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.03%	1.54B

Alternative Medicine

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Alternative Medicine